Top

Published in:

Open Access 01-12-2021 | Heart Surgery | Research

Early recognition of cardiac surgery-associated acute kidney injury: lack of added value of TIMP2 IGFBP7 over short-term changes in creatinine (an observational pilot study)

Authors: Karim Lakhal, Edith Bigot-Corbel, Emilie Sacchetto, Floris Chabrun, Thomas Senage, Lucile Figueres, Maxime Leroy, Arnaud Legrand, Bertrand Rozec

Published in: BMC Anesthesiology | Issue 1/2021

Abstract

Background

For the detection of cardiac surgery-associated acute kidney injury (CS-AKI), the performance of urine tissue inhibitor of metalloproteinase 2 insulin-like growth factor-binding protein 7 (TIMP2 IGFBP7) has never been compared with that of very early changes in plasma creatinine (∆pCr). We hypothesized that, in the context of perioperative haemodilution, lack of postoperative decrease in pCr would be of honourable performance for the detection of CS-AKI. We therefore aimed at comparing these biomarkers and their kinetics (primary objective). As secondary objectives, we assessed plasma neutrophil gelatinase-associated lipocalin (pNGAL), cystatin C (pCysC) and urea (pUrea). We also determined the ability of these biomarkers to early discriminate persistent from transient CS-AKI.

Methods

Patients over 75 years-old undergoing aortic valve replacement with cardiopulmonary bypass (CPB) were included in this prospective observational study. Biomarkers were measured before/after CPB and at the sixth postoperative hour (H6).

Results

In 65 patients, CS-AKI occurred in 27 (42%). ∆pCr from post-CPB to H6 (∆pCr_postCPB-H6): outperformed TIMP2 IGFBP7 at H6 and its intra- or postoperative changes: area under the receiver operating characteristic curve (AUC_ROC) of 0.84 [95%CI:0.73–0.92] vs. ≤0.67 [95%CI:0.54–0.78], p ≤ 0.03. The AUC_ROC of pNGAL, pCysC and pUrea did not exceed 0.72 [95%CI:0.59–0.83]. Indexing biomarkers levels for blood or urine dilution did not improve their performance. Combining TIMP2 IGFBP7 and ∆pCr_postCPB-H6 was of no evident added value over considering ∆pCr_postCPB-H6 alone. For the early recognition of persistent CS-AKI, no biomarker outperformed ∆pCr_postCPB-H6 (AUC_ROC = 0.69 [95%CI:0.48–0.85]).

Conclusions

In this hypothesis-generating study mostly testing early detection of mild CS-AKI, there was no evident added value of the tested modern biomarkers over early minimal postoperative changes in pCr: despite the common perioperative hemodilution in the setting of cardiac surgery, if pCr failed to decline within the 6 h after CPB, the development of CS-AKI was likely. Confirmatory studies with more severe forms of CS-AKI are required.

Available only for authorised users

Priyanka P, Zarbock A, Izawa J, Gleason TG, Renfurm RW, Kellum JA. The impact of acute kidney injury by serum creatinine or urine output criteria on major adverse kidney events in cardiac surgery patients. J Thorac Cardiovasc Surg. 2020. https://doi.org/10.1016/j.jtcvs.2019.11.137.

Petäjä L, Vaara S, Liuhanen S, Suojaranta-Ylinen R, Mildh L, Nisula S, et al. Acute kidney injury after cardiac surgery by complete KDIGO criteria predicts increased mortality. J Cardiothorac Vasc Anesth. 2017;31(3):827–36. https://doi.org/10.1053/j.jvca.2016.08.026.

Howitt SH, Grant SW, Caiado C, Carlson E, Kwon D, Dimarakis I, et al. The KDIGO acute kidney injury guidelines for cardiac surgery patients in critical care: a validation study. BMC Nephrol. 2018;19(1):149. https://doi.org/10.1186/s12882-018-0946-x.

KDIGO. Clinical practice guideline for acute kidney. Injury. 2012;2(Suppl. 1):141.

Wasung ME, Chawla LS, Madero M. Biomarkers of renal function, which and when? Clin Chim Acta. 2015;438:350–7. https://doi.org/10.1016/j.cca.2014.08.039.

Gaffney AM, Sladen RN. Acute kidney injury in cardiac surgery. Curr Opin Anaesthesiol. 2015;28(1):50–9. https://doi.org/10.1097/ACO.0000000000000154.

Bihorac A, Chawla LS, Shaw AD, al-Khafaji A, Davison DL, DeMuth GE, et al. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Am J Respir Crit Care Med. 2014;189(8):932–9. https://doi.org/10.1164/rccm.201401-0077OC.

Kashani K, Al-Khafaji A, Ardiles T, et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care Lond Engl. 2013;17(1):R25. https://doi.org/10.1186/cc12503.

Su L-J, Li Y-M, Kellum JA, Peng ZY. Predictive value of cell cycle arrest biomarkers for cardiac surgery-associated acute kidney injury: a meta-analysis. Br J Anaesth. 2018;121(2):350–7. https://doi.org/10.1016/j.bja.2018.02.069.

10.

Ostermann M, Zarbock A, Goldstein S, Kashani K, Macedo E, Murugan R, et al. Recommendations on acute kidney injury biomarkers from the acute disease quality initiative consensus conference: a consensus statement. JAMA Netw Open. 2020;3(10):e2019209. https://doi.org/10.1001/jamanetworkopen.2020.19209.

11.

Meersch M, Schmidt C, Van Aken H, et al. Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery. PLoS One. 2014;9(3):e93460. https://doi.org/10.1371/journal.pone.0093460.

12.

Ho J, Tangri N, Komenda P, Kaushal A, Sood M, Brar R, et al. Urinary, plasma, and serum biomarkers’ utility for predicting acute kidney injury associated with cardiac surgery in adults: a meta-analysis. Am J Kidney. 2015;66(6):993–1005. https://doi.org/10.1053/j.ajkd.2015.06.018.

13.

McIlroy DR, Farkas D, Matto M, et al. Neutrophil gelatinase-associated lipocalin combined with delta serum creatinine provides early risk stratification for adverse outcomes after cardiac surgery: a prospective observational study. Crit Care Med. 2015;43(5):1043–52. https://doi.org/10.1097/CCM.0000000000000927.

14.

Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983;148(3):839–43. https://doi.org/10.1148/radiology.148.3.6878708.

15.

Chawla LS, Bellomo R, Bihorac A, et al. Acute kidney disease and renal recovery: consensus report of the acute disease quality initiative (ADQI) 16 workgroup. Nat Rev Nephrol. 2017;13(4):241–57. https://doi.org/10.1038/nrneph.2017.2.

16.

Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chem. 2003;49(1):7–18. https://doi.org/10.1373/49.1.7.

17.

Gocze I, Koch M, Renner P, Zeman F, Graf BM, Dahlke MH, et al. Urinary biomarkers TIMP-2 and IGFBP7 early predict acute kidney injury after major surgery. PLoS One. 2015;10(3):e0120863. https://doi.org/10.1371/journal.pone.0120863.

18.

Najjar M, Yerebakan H, Sorabella RA, Donovan DJ, Kossar AP, Sreekanth S, et al. Acute kidney injury following surgical aortic valve replacement. J Card Surg. 2015;30(8):631–9. https://doi.org/10.1111/jocs.12586.

19.

Guzzi LM, Bergler T, Binnall B, Engelman DT, Forni L, Germain MJ, et al. Clinical use of [TIMP-2] [IGFBP7] biomarker testing to assess risk of acute kidney injury in critical care: guidance from an expert panel. Crit Care Lond Engl. 2019;23(1):225. https://doi.org/10.1186/s13054-019-2504-8.

20.

Zaouter C, Potvin J, Bats M-L, Beauvieux MC, Remy A, Ouattara A. A combined approach for the early recognition of acute kidney injury after adult cardiac surgery. Anaesth Crit Care Pain Med. 2018;37(4):335–41. https://doi.org/10.1016/j.accpm.2018.05.001.

21.

Grieshaber P, Möller S, Arneth B, et al. Predicting cardiac surgery-associated acute kidney injury using a combination of clinical risk scores and urinary biomarkers. Thorac Cardiovasc Surg. 2019;68:388–99.

22.

Zaouter C, Priem F, Leroux L, Bonnet G, Bats ML, Beauvieux MC, et al. New markers for early detection of acute kidney injury after transcatheter aortic valve implantation. Anaesth Crit Care Pain Med. 2018;37(4):319–26. https://doi.org/10.1016/j.accpm.2017.10.004.

23.

Wetz AJ, Richardt EM, Wand S, Kunze N, Schotola H, Quintel M, et al. Quantification of urinary TIMP-2 and IGFBP-7: an adequate diagnostic test to predict acute kidney injury after cardiac surgery? Crit Care Lond Engl. 2015;19(1):3. https://doi.org/10.1186/s13054-014-0717-4.

24.

Cummings JJ, Shaw AD, Shi J, et al. Intraoperative prediction of cardiac surgery-associated acute kidney injury using urinary biomarkers of cell cycle arrest. J Thorac Cardiovasc Surg. 2019;157:1545–1553.e5.

25.

Oezkur M, Magyar A, Thomas P, Stork T, Schneider R, Bening C, et al. TIMP-2*IGFBP7 (Nephrocheck®) measurements at intensive care unit admission after cardiac surgery are predictive for acute kidney injury within 48 hours. Kidney Blood Press Res. 2017;42(3):456–67. https://doi.org/10.1159/000479298.

26.

Finge T, Bertran S, Roger C, Candela D, Pereira B, Scott C, et al. Interest of urinary [TIMP-2] x [IGFBP-7] for predicting the occurrence of acute kidney injury after cardiac surgery: a gray zone approach. Anesth Analg. 2017;125(3):762–9. https://doi.org/10.1213/ANE.0000000000002116.

27.

Gist KM, Goldstein SL, Wrona J, Alten JA, Basu RK, Cooper DS, et al. Kinetics of the cell cycle arrest biomarkers (TIMP-2*IGFBP-7) for prediction of acute kidney injury in infants after cardiac surgery. Pediatr Nephrol. 2017;32(9):1611–9. https://doi.org/10.1007/s00467-017-3655-y.

28.

Dusse F, Edayadiyil-Dudásova M, Thielmann M, et al. Early prediction of acute kidney injury after transapical and transaortic aortic valve implantation with urinary G1 cell cycle arrest biomarkers. BMC Anesthesiol. 2016;16:76.

29.

Meersch M, Schmidt C, Van Aken H, et al. Validation of cell-cycle arrest biomarkers for acute kidney injury after pediatric cardiac surgery. PLoS One. 2014;9(10):e110865. https://doi.org/10.1371/journal.pone.0110865.

30.

Bernardi MH, Ristl R, Neugebauer T, Hiesmayr MJ, Druml W, Lassnigg A. Very early changes in serum creatinine are associated with 30-day mortality after cardiac surgery: a cohort study. Eur J Anaesthesiol. 2020;37(10):898–907. https://doi.org/10.1097/EJA.0000000000001214.

31.

Ho J, Reslerova M, Gali B, Nickerson PW, Rush DN, Sood MM, et al. Serum creatinine measurement immediately after cardiac surgery and prediction of acute kidney injury. Am J Kidney Dis. 2012;59(2):196–201. https://doi.org/10.1053/j.ajkd.2011.08.023.

32.

Streiner DL. Best (but oft-forgotten) practices: the multiple problems of multiplicity-whether and how to correct for many statistical tests. Am J Clin Nutr. 2015;102(4):721–8. Epub 2015 Aug 5. https://doi.org/10.3945/ajcn.115.113548.

33.

Lassnigg A, Schmidlin D, Mouhieddine M, Bachmann LM, Druml W, Bauer P, et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol. 2004;15(6):1597–605. https://doi.org/10.1097/01.ASN.0000130340.93930.DD.

34.

Reardon MJ, Van Mieghem NM, Popma JJ, et al. Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients. N. Engl. J. Med. 2017;376:1321–31.

35.

Tolpin DA, Collard CD, Lee V-V, et al. Subclinical changes in serum creatinine and mortality after coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2012;143:682–688.e1.

36.

Meersch M, Schmidt C, Hoffmeier A, Van Aken H, Wempe C, Gerss J, Zarbock A. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial. Intensive Care Med. 2017;43(11):1551-1561. Epub 2017 Jan 21. https://doi.org/10.1007/s00134-016-4670-3.

Title: Early recognition of cardiac surgery-associated acute kidney injury: lack of added value of TIMP2 IGFBP7 over short-term changes in creatinine (an observational pilot study)
Authors: Karim Lakhal
Edith Bigot-Corbel
Emilie Sacchetto
Floris Chabrun
Thomas Senage
Lucile Figueres
Maxime Leroy
Arnaud Legrand
Bertrand Rozec
Publication date: 01-12-2021
Publisher: BioMed Central
Keywords: Heart Surgery
Acute Kidney Injury
Insulins
Heart Surgery
Acute Kidney Injury
Insulins
Biomarkers
Published in: BMC Anesthesiology / Issue 1/2021
Electronic ISSN: 1471-2253
DOI: https://doi.org/10.1186/s12871-021-01387-6

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Early recognition of cardiac surgery-associated acute kidney injury: lack of added value of TIMP2 IGFBP7 over short-term changes in creatinine (an observational pilot study)

Abstract

Background

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2021

Evaluation of radial and ulnar artery blood flow after radial artery decannulation using colour Doppler ultrasound

Risk factors for unplanned reintubation caused by acute airway compromise after general anesthesia: a case-control study

Effects of sevoflurane anesthesia and abdominal surgery on the systemic metabolome: a prospective observational study

Safety application of muscle relaxants and the traditional low-frequency ventilation during the flexible or rigid bronchoscopy in patients with central airway obstruction: a retrospective observational study

Economic impact of improving patient safety using Sugammadex for routine reversal of neuromuscular blockade in Spain

Sevoflurane blocks glioma malignant development by upregulating circRELN through circRELN-mediated miR-1290/RORA axis